A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy of PCSK-9 Inhibitors in Delaying the Progression of Calcified Aortic Valve Disease

Clinical trial NCT06996223 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06996223
Sponsor: Nanfang Hospital, Southern Medical University
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Aortic Stenosis PCSK9 Inhibitor Calcified Aortic Valve Disease

Start date: 2025-06-01
Primary completion: 2027-06-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.